MOLOGEN AG receives approval for clinical study with cell-based gene therapy ... - PharmaLive.com (press release) Print
PharmaLive.com (press release)MGN1601 is a cell-based gene therapy for the treatment of advanced renal cancer. The responsible ethics committee has also agreed to the execution of the

... read more